Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy

Heng Li, Gan Yu, Runlin Shi, Bin Lang, Xianguo Chen, Ding Xia, Haibing Xiao, Xiaolin Guo, Wei Guan, Zhangqun Ye, Wei Xiao, Hua Xu

Research output: Contribution to journalArticlepeer-review

50 Citations (Scopus)

Abstract

Background: Accumulating evidence suggests a tumor suppressive role for miR-34a in human carcinogenesis. However, its precise biological role remains largely elusive. This study aimed to reveal the association of the miR-34a expression and its modulation of sensitivity to cisplatin in muscle-invasive bladder cancer (MIBC).Methods: miR-34a expression in MIBC cell lines and patient tissues was investigated using qPCR. The methylation analysis of miR-34a promoter region was performed by MassARRAY. Synthetic short single or double stranded RNA oligonucleotides and lentiviral vector were used to regulate miR-34a expression in MIBC cells to investigate its function in vitro and in vivo. Results: miR-34a expression was frequently decreased in MIBC tissues and cell lines through promoter hypermethylation while it was epigenetically increased in MIBC cells following cisplatin treatment. Increased miR-34a expression significantly sensitized MIBC cells to cisplatin and inhibited the tumorigenicity and proliferation of cancer cells in vitro and in vivo. Furthermore, we identified CD44 as being targeted by miR-34a in MIBC cells following cisplatin treatment, and increased CD44 expression could efficiently reverse the effect of miR-34a on MIBC cell proliferation, colongenic potential and chemosensitivity. Conclusions: Cisplatin-based chemotherapy induced demethylation of miR-34a promoter and increased miR-34a expression, which in turn sensitized MIBC cells to cisplatin and decreased the tumorigenicity and proliferation of cancer cells that by reducing the production of CD44.

Original languageEnglish
Article number8
JournalMolecular Cancer
Volume13
Issue number1
DOIs
Publication statusPublished - 15 Jan 2014

Keywords

  • CD44
  • Chemosensitivity
  • Muscle invasive bladder cancer
  • Promoter hypermethylation
  • miR-34a

Fingerprint

Dive into the research topics of 'Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy'. Together they form a unique fingerprint.

Cite this